Reviews Cyclosporine


No reviews yet.

Neoral Drug Description
NEORAL®
(cyclosporine) Soft Gelatin Capsules, USP MODIFIED
NEORAL®
(cyclosporine) Oral Solution, USP MODIFIED

WARNING
Only physicians experienced in management of systemic immunosuppressive therapy for the indicated disease should prescribe Neoral®. At doses used in solid organ transplantation, only physicians experienced in immunosuppressive therapy and management of organ transplant recipients should prescribe Neoral®. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.
Neoral®, a systemic immunosuppressant, may increase the susceptibility to infection and the development of neoplasia. In kidney, liver, and heart transplant patients Neoral® may be administered with other immunosuppressive agents. Increased susceptibility to infection and the possible development of lymphoma and other neoplasms may result from the increase in the degree of immunosuppression in transplant patients.
Neoral® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED and Neoral® Oral Solution (cyclosporine oral solution, USP) MODIFIED have increased bioavailability in comparison to Sandimmune® Soft Gelatin Capsules (cyclosporine capsules, USP) and Sandimmune® Oral Solution (cyclosporine oral solution, USP). Neoral® and Sandimmune® are not bioequivalent and cannot be used interchangeably without physician supervision. For a given trough concentration, cyclosporine exposure will be greater with Neoral® than with Sandimmune®. If a patient who is receiving exceptionally high doses of Sandimmune® is converted to Neoral®, particular caution should be exercised. Cyclosporine blood concentrations should be monitored in transplant and rheumatoid arthritis patients taking Neoral® to avoid toxicity due to high concentrations. Dose adjustments should be made in transplant patients to minimize possible organ rejection due to low concentrations. Comparison of blood concentrations in the published literature with blood concentrations obtained using current assays must be done with detailed knowledge of the assay methods employed.
For Psoriasis Patients (See also Boxed WARNINGS above)
Psoriasis patients previously treated with PUVA and to a lesser extent, methotrexate or other immunosuppressive agents, UVB, coal tar, or radiation therapy, are at an increased risk of developing skin malignancies when taking Neoral®.
Cyclosporine, the active ingredient in Neoral®, in recommended dosages, can cause systemic hypertension and nephrotoxicity. The risk increases with increasing dose and duration of cyclosporine therapy. Renal dysfunction, including structural kidney damage, is a potential consequence of cyclosporine, and therefore, renal function must be monitored during therapy.

DRUG DESCRIPTION



What are the possible side effects of cyclosporine (Gengraf, Neoral, Sandimmune)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

urinating less than usual or not at all;
drowsiness, confusion, mood changes, increased thirst;
swelling, weight gain, feeling short of breath;
blurred vision, headache or pain behind your eyes, sometimes...
Read All Potential Side Effects for Neoral »




Neoral® is an oral formulation of cyclosporine that immediately forms a microemulsion in an aqueous environment.
Cyclosporine, the active principle in Neoral®, is a cyclic polypeptide
immunosuppressant agent consisting of 11 amino acids. It is produced as a metabolite
by the fungus species Beauveria nivea.
Chemically, cyclosporine is designated as [R-[R*,R*-(E)]]-cyclic-(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-α-amino-butyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl).
Neoral® Soft Gelatin Capsules
(cyclosporine) Capsules, USP MODIFIED are available in 25 mg and 100 mg strengths.
Each 25 mg capsule contains:
cyclosporine.............................................................25
mg
alcohol, USP dehydrated.............................................................11.9%
v/v (9.5% wt/vol.)
Each 100 mg capsule contains:
cyclosporine.............................................................100
mg
alcohol, USP dehydrated.............................................................11.9%
v/v (9.5% wt/vol.)
Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl
40 hydrogenated castor oil NF, DL-α tocopherol USP, gelatin NF, glycerol, iron
oxide black, propylene glycol USP, titanium dioxide USP, carmine, and other
ingredients.
Neoral® Oral Solution
(cyclosporine) Oral Solution, USP MODIFIED is available in 50 mL bottles.
Each mL contains:
cyclosporine......................................100 mg/mL
alcohol, USP dehydrated...............................11.9% v/v (9.5% wt/vol.)
Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl
40 hydrogenated castor oil NF, DL-α tocopherol USP, propylene glycol USP.
The chemical structure of cyclosporine (also known as cyclosporin A) is:







Last reviewed on RxList: 10/14/2009




Neoral Drug Description
NEORAL®
(cyclosporine) Soft Gelatin Capsules, USP MODIFIED
NEORAL®
(cyclosporine) Oral Solution, USP MODIFIED

WARNING
Only physicians experienced in management of systemic immunosuppressive therapy for the indicated disease should prescribe Neoral®. At doses used in solid organ transplantation, only physicians experienced in immunosuppressive therapy and management of organ transplant recipients should prescribe Neoral®. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.
Neoral®, a systemic immunosuppressant, may increase the susceptibility to infection and the development of neoplasia. In kidney, liver, and heart transplant patients Neoral® may be administered with other immunosuppressive agents. Increased susceptibility to infection and the possible development of lymphoma and other neoplasms may result from the increase in the degree of immunosuppression in transplant patients.
Neoral® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED and Neoral® Oral Solution (cyclosporine oral solution, USP) MODIFIED have increased bioavailability in comparison to Sandimmune® Soft Gelatin Capsules (cyclosporine capsules, USP) and Sandimmune® Oral Solution (cyclosporine oral solution, USP). Neoral® and Sandimmune® are not bioequivalent and cannot be used interchangeably without physician supervision. For a given trough concentration, cyclosporine exposure will be greater with Neoral® than with Sandimmune®. If a patient who is receiving exceptionally high doses of Sandimmune® is converted to Neoral®, particular caution should be exercised. Cyclosporine blood concentrations should be monitored in transplant and rheumatoid arthritis patients taking Neoral® to avoid toxicity due to high concentrations. Dose adjustments should be made in transplant patients to minimize possible organ rejection due to low concentrations. Comparison of blood concentrations in the published literature with blood concentrations obtained using current assays must be done with detailed knowledge of the assay methods employed.
For Psoriasis Patients (See also Boxed WARNINGS above)
Psoriasis patients previously treated with PUVA and to a lesser extent, methotrexate or other immunosuppressive agents, UVB, coal tar, or radiation therapy, are at an increased risk of developing skin malignancies when taking Neoral®.
Cyclosporine, the active ingredient in Neoral®, in recommended dosages, can cause systemic hypertension and nephrotoxicity. The risk increases with increasing dose and duration of cyclosporine therapy. Renal dysfunction, including structural kidney damage, is a potential consequence of cyclosporine, and therefore, renal function must be monitored during therapy.

DRUG DESCRIPTION



What are the possible side effects of cyclosporine (Gengraf, Neoral, Sandimmune)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

urinating less than usual or not at all;
drowsiness, confusion, mood changes, increased thirst;
swelling, weight gain, feeling short of breath;
blurred vision, headache or pain behind your eyes, sometimes...
Read All Potential Side Effects for Neoral »




Neoral® is an oral formulation of cyclosporine that immediately forms a microemulsion in an aqueous environment.
Cyclosporine, the active principle in Neoral®, is a cyclic polypeptide
immunosuppressant agent consisting of 11 amino acids. It is produced as a metabolite
by the fungus species Beauveria nivea.
Chemically, cyclosporine is designated as [R-[R*,R*-(E)]]-cyclic-(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-α-amino-butyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl).
Neoral® Soft Gelatin Capsules
(cyclosporine) Capsules, USP MODIFIED are available in 25 mg and 100 mg strengths.
Each 25 mg capsule contains:
cyclosporine.............................................................25
mg
alcohol, USP dehydrated.............................................................11.9%
v/v (9.5% wt/vol.)
Each 100 mg capsule contains:
cyclosporine.............................................................100
mg
alcohol, USP dehydrated.............................................................11.9%
v/v (9.5% wt/vol.)
Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl
40 hydrogenated castor oil NF, DL-α tocopherol USP, gelatin NF, glycerol, iron
oxide black, propylene glycol USP, titanium dioxide USP, carmine, and other
ingredients.
Neoral® Oral Solution
(cyclosporine) Oral Solution, USP MODIFIED is available in 50 mL bottles.
Each mL contains:
cyclosporine......................................100 mg/mL
alcohol, USP dehydrated...............................11.9% v/v (9.5% wt/vol.)
Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl
40 hydrogenated castor oil NF, DL-α tocopherol USP, propylene glycol USP.
The chemical structure of cyclosporine (also known as cyclosporin A) is:







Last reviewed on RxList: 10/14/2009




Neoral Drug Description
NEORAL®
(cyclosporine) Soft Gelatin Capsules, USP MODIFIED
NEORAL®
(cyclosporine) Oral Solution, USP MODIFIED

WARNING
Only physicians experienced in management of systemic immunosuppressive therapy for the indicated disease should prescribe Neoral®. At doses used in solid organ transplantation, only physicians experienced in immunosuppressive therapy and management of organ transplant recipients should prescribe Neoral®. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.
Neoral®, a systemic immunosuppressant, may increase the susceptibility to infection and the development of neoplasia. In kidney, liver, and heart transplant patients Neoral® may be administered with other immunosuppressive agents. Increased susceptibility to infection and the possible development of lymphoma and other neoplasms may result from the increase in the degree of immunosuppression in transplant patients.
Neoral® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED and Neoral® Oral Solution (cyclosporine oral solution, USP) MODIFIED have increased bioavailability in comparison to Sandimmune® Soft Gelatin Capsules (cyclosporine capsules, USP) and Sandimmune® Oral Solution (cyclosporine oral solution, USP). Neoral® and Sandimmune® are not bioequivalent and cannot be used interchangeably without physician supervision. For a given trough concentration, cyclosporine exposure will be greater with Neoral® than with Sandimmune®. If a patient who is receiving exceptionally high doses of Sandimmune® is converted to Neoral®, particular caution should be exercised. Cyclosporine blood concentrations should be monitored in transplant and rheumatoid arthritis patients taking Neoral® to avoid toxicity due to high concentrations. Dose adjustments should be made in transplant patients to minimize possible organ rejection due to low concentrations. Comparison of blood concentrations in the published literature with blood concentrations obtained using current assays must be done with detailed knowledge of the assay methods employed.
For Psoriasis Patients (See also Boxed WARNINGS above)
Psoriasis patients previously treated with PUVA and to a lesser extent, methotrexate or other immunosuppressive agents, UVB, coal tar, or radiation therapy, are at an increased risk of developing skin malignancies when taking Neoral®.
Cyclosporine, the active ingredient in Neoral®, in recommended dosages, can cause systemic hypertension and nephrotoxicity. The risk increases with increasing dose and duration of cyclosporine therapy. Renal dysfunction, including structural kidney damage, is a potential consequence of cyclosporine, and therefore, renal function must be monitored during therapy.

DRUG DESCRIPTION



What are the possible side effects of cyclosporine (Gengraf, Neoral, Sandimmune)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

urinating less than usual or not at all;
drowsiness, confusion, mood changes, increased thirst;
swelling, weight gain, feeling short of breath;
blurred vision, headache or pain behind your eyes, sometimes...
Read All Potential Side Effects for Neoral »




Neoral® is an oral formulation of cyclosporine that immediately forms a microemulsion in an aqueous environment.
Cyclosporine, the active principle in Neoral®, is a cyclic polypeptide
immunosuppressant agent consisting of 11 amino acids. It is produced as a metabolite
by the fungus species Beauveria nivea.
Chemically, cyclosporine is designated as [R-[R*,R*-(E)]]-cyclic-(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-α-amino-butyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl).
Neoral® Soft Gelatin Capsules
(cyclosporine) Capsules, USP MODIFIED are available in 25 mg and 100 mg strengths.
Each 25 mg capsule contains:
cyclosporine.............................................................25
mg
alcohol, USP dehydrated.............................................................11.9%
v/v (9.5% wt/vol.)
Each 100 mg capsule contains:
cyclosporine.............................................................100
mg
alcohol, USP dehydrated.............................................................11.9%
v/v (9.5% wt/vol.)
Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl
40 hydrogenated castor oil NF, DL-α tocopherol USP, gelatin NF, glycerol, iron
oxide black, propylene glycol USP, titanium dioxide USP, carmine, and other
ingredients.
Neoral® Oral Solution
(cyclosporine) Oral Solution, USP MODIFIED is available in 50 mL bottles.
Each mL contains:
cyclosporine......................................100 mg/mL
alcohol, USP dehydrated...............................11.9% v/v (9.5% wt/vol.)
Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl
40 hydrogenated castor oil NF, DL-α tocopherol USP, propylene glycol USP.
The chemical structure of cyclosporine (also known as cyclosporin A) is:







Last reviewed on RxList: 10/14/2009




Neoral Drug Description
NEORAL®
(cyclosporine) Soft Gelatin Capsules, USP MODIFIED
NEORAL®
(cyclosporine) Oral Solution, USP MODIFIED

WARNING
Only physicians experienced in management of systemic immunosuppressive therapy for the indicated disease should prescribe Neoral®. At doses used in solid organ transplantation, only physicians experienced in immunosuppressive therapy and management of organ transplant recipients should prescribe Neoral®. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.
Neoral®, a systemic immunosuppressant, may increase the susceptibility to infection and the development of neoplasia. In kidney, liver, and heart transplant patients Neoral® may be administered with other immunosuppressive agents. Increased susceptibility to infection and the possible development of lymphoma and other neoplasms may result from the increase in the degree of immunosuppression in transplant patients.
Neoral® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED and Neoral® Oral Solution (cyclosporine oral solution, USP) MODIFIED have increased bioavailability in comparison to Sandimmune® Soft Gelatin Capsules (cyclosporine capsules, USP) and Sandimmune® Oral Solution (cyclosporine oral solution, USP). Neoral® and Sandimmune® are not bioequivalent and cannot be used interchangeably without physician supervision. For a given trough concentration, cyclosporine exposure will be greater with Neoral® than with Sandimmune®. If a patient who is receiving exceptionally high doses of Sandimmune® is converted to Neoral®, particular caution should be exercised. Cyclosporine blood concentrations should be monitored in transplant and rheumatoid arthritis patients taking Neoral® to avoid toxicity due to high concentrations. Dose adjustments should be made in transplant patients to minimize possible organ rejection due to low concentrations. Comparison of blood concentrations in the published literature with blood concentrations obtained using current assays must be done with detailed knowledge of the assay methods employed.
For Psoriasis Patients (See also Boxed WARNINGS above)
Psoriasis patients previously treated with PUVA and to a lesser extent, methotrexate or other immunosuppressive agents, UVB, coal tar, or radiation therapy, are at an increased risk of developing skin malignancies when taking Neoral®.
Cyclosporine, the active ingredient in Neoral®, in recommended dosages, can cause systemic hypertension and nephrotoxicity. The risk increases with increasing dose and duration of cyclosporine therapy. Renal dysfunction, including structural kidney damage, is a potential consequence of cyclosporine, and therefore, renal function must be monitored during therapy.

DRUG DESCRIPTION



What are the possible side effects of cyclosporine (Gengraf, Neoral, Sandimmune)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

urinating less than usual or not at all;
drowsiness, confusion, mood changes, increased thirst;
swelling, weight gain, feeling short of breath;
blurred vision, headache or pain behind your eyes, sometimes...
Read All Potential Side Effects for Neoral »




Neoral® is an oral formulation of cyclosporine that immediately forms a microemulsion in an aqueous environment.
Cyclosporine, the active principle in Neoral®, is a cyclic polypeptide
immunosuppressant agent consisting of 11 amino acids. It is produced as a metabolite
by the fungus species Beauveria nivea.
Chemically, cyclosporine is designated as [R-[R*,R*-(E)]]-cyclic-(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-α-amino-butyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl).
Neoral® Soft Gelatin Capsules
(cyclosporine) Capsules, USP MODIFIED are available in 25 mg and 100 mg strengths.
Each 25 mg capsule contains:
cyclosporine.............................................................25
mg
alcohol, USP dehydrated.............................................................11.9%
v/v (9.5% wt/vol.)
Each 100 mg capsule contains:
cyclosporine.............................................................100
mg
alcohol, USP dehydrated.............................................................11.9%
v/v (9.5% wt/vol.)
Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl
40 hydrogenated castor oil NF, DL-α tocopherol USP, gelatin NF, glycerol, iron
oxide black, propylene glycol USP, titanium dioxide USP, carmine, and other
ingredients.
Neoral® Oral Solution
(cyclosporine) Oral Solution, USP MODIFIED is available in 50 mL bottles.
Each mL contains:
cyclosporine......................................100 mg/mL
alcohol, USP dehydrated...............................11.9% v/v (9.5% wt/vol.)
Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl
40 hydrogenated castor oil NF, DL-α tocopherol USP, propylene glycol USP.
The chemical structure of cyclosporine (also known as cyclosporin A) is:







Last reviewed on RxList: 10/14/2009




Neoral Drug Description
NEORAL®
(cyclosporine) Soft Gelatin Capsules, USP MODIFIED
NEORAL®
(cyclosporine) Oral Solution, USP MODIFIED

WARNING
Only physicians experienced in management of systemic immunosuppressive therapy for the indicated disease should prescribe Neoral®. At doses used in solid organ transplantation, only physicians experienced in immunosuppressive therapy and management of organ transplant recipients should prescribe Neoral®. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.
Neoral®, a systemic immunosuppressant, may increase the susceptibility to infection and the development of neoplasia. In kidney, liver, and heart transplant patients Neoral® may be administered with other immunosuppressive agents. Increased susceptibility to infection and the possible development of lymphoma and other neoplasms may result from the increase in the degree of immunosuppression in transplant patients.
Neoral® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED and Neoral® Oral Solution (cyclosporine oral solution, USP) MODIFIED have increased bioavailability in comparison to Sandimmune® Soft Gelatin Capsules (cyclosporine capsules, USP) and Sandimmune® Oral Solution (cyclosporine oral solution, USP). Neoral® and Sandimmune® are not bioequivalent and cannot be used interchangeably without physician supervision. For a given trough concentration, cyclosporine exposure will be greater with Neoral® than with Sandimmune®. If a patient who is receiving exceptionally high doses of Sandimmune® is converted to Neoral®, particular caution should be exercised. Cyclosporine blood concentrations should be monitored in transplant and rheumatoid arthritis patients taking Neoral® to avoid toxicity due to high concentrations. Dose adjustments should be made in transplant patients to minimize possible organ rejection due to low concentrations. Comparison of blood concentrations in the published literature with blood concentrations obtained using current assays must be done with detailed knowledge of the assay methods employed.
For Psoriasis Patients (See also Boxed WARNINGS above)
Psoriasis patients previously treated with PUVA and to a lesser extent, methotrexate or other immunosuppressive agents, UVB, coal tar, or radiation therapy, are at an increased risk of developing skin malignancies when taking Neoral®.
Cyclosporine, the active ingredient in Neoral®, in recommended dosages, can cause systemic hypertension and nephrotoxicity. The risk increases with increasing dose and duration of cyclosporine therapy. Renal dysfunction, including structural kidney damage, is a potential consequence of cyclosporine, and therefore, renal function must be monitored during therapy.

DRUG DESCRIPTION



What are the possible side effects of cyclosporine (Gengraf, Neoral, Sandimmune)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

urinating less than usual or not at all;
drowsiness, confusion, mood changes, increased thirst;
swelling, weight gain, feeling short of breath;
blurred vision, headache or pain behind your eyes, sometimes...
Read All Potential Side Effects for Neoral »




Neoral® is an oral formulation of cyclosporine that immediately forms a microemulsion in an aqueous environment.
Cyclosporine, the active principle in Neoral®, is a cyclic polypeptide
immunosuppressant agent consisting of 11 amino acids. It is produced as a metabolite
by the fungus species Beauveria nivea.
Chemically, cyclosporine is designated as [R-[R*,R*-(E)]]-cyclic-(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-α-amino-butyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl).
Neoral® Soft Gelatin Capsules
(cyclosporine) Capsules, USP MODIFIED are available in 25 mg and 100 mg strengths.
Each 25 mg capsule contains:
cyclosporine.............................................................25
mg
alcohol, USP dehydrated.............................................................11.9%
v/v (9.5% wt/vol.)
Each 100 mg capsule contains:
cyclosporine.............................................................100
mg
alcohol, USP dehydrated.............................................................11.9%
v/v (9.5% wt/vol.)
Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl
40 hydrogenated castor oil NF, DL-α tocopherol USP, gelatin NF, glycerol, iron
oxide black, propylene glycol USP, titanium dioxide USP, carmine, and other
ingredients.
Neoral® Oral Solution
(cyclosporine) Oral Solution, USP MODIFIED is available in 50 mL bottles.
Each mL contains:
cyclosporine......................................100 mg/mL
alcohol, USP dehydrated...............................11.9% v/v (9.5% wt/vol.)
Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl
40 hydrogenated castor oil NF, DL-α tocopherol USP, propylene glycol USP.
The chemical structure of cyclosporine (also known as cyclosporin A) is:







Last reviewed on RxList: 10/14/2009





Other reviews about Cyclosporine on wordpress

Licorice May Block Absorption of Organ Transplant Drug
  by timeinctemp
TUESDAY, March 24 (HealthDay News) — People taking the immunosuppressant cyclosporine should avoid consuming licorice because it may weaken the drug's effectiveness and possibly lead to deadly consequences, […]


FDA MedWatch - Sirolimus, Cyclosporine, Cyclosporine modified, Mycophenolate mofetil, and Mycophenolic acid
  by irbtipoftheweek
Sirolimus (marketed as Rapamune), Cyclosporine (marketed as Sandimmune and generics), Cyclosporine modified (marketed as Neoral and generics), Mycophenolate mofetil (marketed as Cellcept and generics), Mycophenolic acid (marketed as […]


Cyclosporine
  by cjohans
We took Nelly in for full blood work today, so we could get a baseline before she starts her cyclosporine tonight.  At the vet's office, Nelly's favorite buddy […]


Cyclosporine Levels are therapeutic now
  by cjohans
We got Nelly's cyclosporine levels back today, and they were at 429 ng/ml, which is within the ideal immunosuppressive range of 400-600.  Although it is hard to tolerate. […]


FDA MedWatch - September 2009 Drug Safety Labeling Changes
  by irbtipoftheweek
The MedWatch September 2009 Drug Safety Labeling Changes posting includes 36 drug products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, […]


Cyclosporine
  by jmcmah239
I found out Monday that I will be taking the chemo drug Cyclosporine once the prior authorization is granted. I got off the chemo drug Cladribine due to […]


Dealing with Stress (continued)
  by jmcmah239
Will this chemotherapy drug work? My platelets have went from 189,000 before chemotherapy to 39,000 with the drug Cladribine. Obviously, Cladribine has been stopped. Cyclosporine doesn't affect platelelets […]


Orgen Transplantaion and Cancer
  by zedie
Cancer is a widely recognized complication of transplantation, and the effects of various immunosuppressive drugs on cancer risk remains controversial. This randomized trial allocated 489 recipients of first […]


Organ-Rejection Drug Linked to Higher Cancer Risk After Liver Transplant
  by nalonsospc
By Steven ReinbergHealthDay Reporter MONDAY, June 28 (HealthDay News) -- Cyclosporine, a drug commonly used to prevent organ rejection following a transplant, has been linked to a significantly increased […]


Cyclosporine Increases Risk for De Novo Cancer in Liver Transplantation
  by zedie
Although the 1-year survival rate after liver transplantation has risen dramatically, patients may be finding themselves at an increased risk for de novo cancer. The risk for de […]



Other reviews about Cyclosporine on web:

Ciclosporin (INN, pronounced /ˌsaɪklɵˈspɔərɨn/), cyclosporine , cyclosporin (former BAN) or cyclosporin A, is an immunosuppressant drug widely used in post-allogeneic organ ... Ciclosporin - Wikipedia, the free encyclopedia


Mayo Clinic offers award-winning medical and health information and tools for healthy living. Cyclosporine (Oral Route, Intravenous Route) - MayoClinic.com


cyclosporine also cyclosporin n. An immunosuppressive drug obtained from certain soil fungi, used mainly to prevent the rejection of transplanted cyclosporine: Definition from Answers.com


Physician reviewed cyclosporine patient information - includes cyclosporine description, dosage and directions. cyclosporine medical facts from Drugs.com


Cyclosporine is available in its original form and as another product that has been modified (changed) so that the medication can be better absorbed in the body. Cyclosporine: MedlinePlus Drug Information


Consumer information about the medication CYCLOSPORINE - IV (Sandimmune), includes side effects, drug interactions, recommended dosages, and storage information. Read more about ... CYCLOSPORINE - IV (Sandimmune) side effects, medical uses, and ...


Accurate, FDA approved Cyclosporine information for healthcare professionals and patients - brought to you by Drugs.com. Cyclosporine Official FDA information, side effects and uses.


Find patient medical information for Cyclosporine Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Cyclosporine Oral : Uses, Side Effects, Interactions, Pictures ...


Cyclosporine (For veterinary information only) Brand Names: Atopica, Neoral, Sandimmune, and Optimmune (Ophthalmic) Available in 0.2% ophthalmic ointment, 10 mg, 25 mg, 50 mg and 100 ... Cyclosporine - VeterinaryPartner.com - a VIN company!


Learn about the prescription medication Sandimmune (Cyclosporine), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Sandimmune (Cyclosporine) Drug Information: Uses, Side Effects ...





Featured Reviews

Reviews Amitiza

Amitiza Drug Description Amitiza® (lubiprostone) Capsules DRUG DESCRIPTION What are the possible side effects of lubiprostone (Amitiza)? Stop using lubiprostone and get emergency medical help if you have any of these signs...
Read More  |  Review This
Reviews Librium

Librium Drug Description LIBRIUM® (chlordiazepoxide HCI) Capsules DRUG DESCRIPTION What are the possible side effects of chlordiazepoxide (Librium)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Desloratadine and Pseudoephedrine Sulfate

Clarinex-D 24hr Drug Description CLARINEX-D® 24 HOUR(desloratadine 5 mg and pseudoephedrine sulfate, USP 240 mg) Extended Release Tablets DRUG DESCRIPTION What are the possible side effects of desloratadine and pseudoephedrine...
Read More  |  Review This
Reviews Memantine HCL

Namenda Drug Description Namenda (memantine hydrochloride) Tablets/Oral Solution DRUG DESCRIPTION What are the possible side effects of memantine (Namenda)? Get emergency medical help if you have any of these signs of an allergic...
Read More  |  Review This
Reviews Tobramycin

Tobramycin Injection Drug Description Tobramycin for Injection USP 1.2 gm† This vial is intended for use by the hospital pharmacist in the extemporaneous preparation of IV solutions. PHARMACY BULK PACKAGE NOT FOR DIRECT...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....